SYROS PHARMACEUTICALS, INC. Marketable Securities (Current)
SYROS PHARMACEUTICALS, INC. had Marketable Securities (Current) of $24.78 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2024-05-14
- 2024-03-31: Marketable Securities, Current $24.78M.
- 2023-06-30: Marketable Securities, Current $28.54M.
- 2023-03-31: Marketable Securities, Current $61.04M.
- 2022-12-31: Marketable Securities, Current $34.84M.
| Period end | Marketable Securities, Current |
|---|---|
| 2024-03-31 | $24.78M 10-Q · filed 2024-05-14 |
| 2023-06-30 | $28.54M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $61.04M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $34.84M 10-K · filed 2024-03-27 |
| 2022-09-30 | $72.95M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $27.22M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $40.69M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $38.07M 10-K · filed 2023-03-02 |
| 2021-09-30 | $30.16M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $21.11M 10-Q · filed 2021-08-05 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 |
| 2020-03-31 | $5.00M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $49.98M 10-K · filed 2021-03-04 |
| 2019-09-30 | $74.77M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $19.98M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $53.74M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $49.79M 10-K · filed 2020-03-05 |
| 2018-09-30 | $69.71M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $9.98M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $27.41M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $39.84M 10-K · filed 2019-03-07 |
| 2017-09-30 | $39.80M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $11.99M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $22.50M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $25.00M 10-K · filed 2018-03-12 |